These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1274 related articles for article (PubMed ID: 15067356)
1. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells. St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356 [TBL] [Abstract][Full Text] [Related]
2. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway. St-Germain ME; Gagnon V; Parent S; Asselin E Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316 [TBL] [Abstract][Full Text] [Related]
3. Akt activity in endometrial cancer cells: regulation of cell survival through cIAP-1. Gagnon V; St-Germain ME; Parent S; Asselin E Int J Oncol; 2003 Sep; 23(3):803-10. PubMed ID: 12888921 [TBL] [Abstract][Full Text] [Related]
4. COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines. Honjo S; Osaki M; Ardyanto TD; Hiramatsu T; Maeta N; Ito H DNA Cell Biol; 2005 Mar; 24(3):141-7. PubMed ID: 15767780 [TBL] [Abstract][Full Text] [Related]
5. Integrin-linked kinase (ILK) regulation of the cell viability in PTEN mutant glioblastoma and in vitro inhibition by the specific COX-2 inhibitor NS-398. Obara S; Nakata M; Takeshima H; Katagiri H; Asano T; Oka Y; Maruyama I; Kuratsu J Cancer Lett; 2004 May; 208(1):115-22. PubMed ID: 15105053 [TBL] [Abstract][Full Text] [Related]
6. AKT involvement in cisplatin chemoresistance of human uterine cancer cells. Gagnon V; Mathieu I; Sexton E; Leblanc K; Asselin E Gynecol Oncol; 2004 Sep; 94(3):785-95. PubMed ID: 15350374 [TBL] [Abstract][Full Text] [Related]
7. Growth suppression activity of the PTEN tumor suppressor gene in human endometrial cancer cells. Lilja JF; Wu D; Reynolds RK; Lin J Anticancer Res; 2001; 21(3B):1969-74. PubMed ID: 11497285 [TBL] [Abstract][Full Text] [Related]
8. Impact of PTEN expression on the outcome of hepatitis C virus-positive cirrhotic hepatocellular carcinoma patients: possible relationship with COX II and inducible nitric oxide synthase. Rahman MA; Kyriazanos ID; Ono T; Yamanoi A; Kohno H; Tsuchiya M; Nagasue N Int J Cancer; 2002 Jul; 100(2):152-7. PubMed ID: 12115563 [TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Leng J; Han C; Demetris AJ; Michalopoulos GK; Wu T Hepatology; 2003 Sep; 38(3):756-68. PubMed ID: 12939602 [TBL] [Abstract][Full Text] [Related]
10. Impact of PTEN on the expression of insulin-like growth factors (IGFs) and IGF-binding proteins in human gastric adenocarcinoma cells. Yi HK; Kim SY; Hwang PH; Kim CY; Yang DH; Oh Y; Lee DY Biochem Biophys Res Commun; 2005 May; 330(3):760-7. PubMed ID: 15809062 [TBL] [Abstract][Full Text] [Related]
11. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Yuan ZQ; Sun M; Feldman RI; Wang G; Ma X; Jiang C; Coppola D; Nicosia SV; Cheng JQ Oncogene; 2000 May; 19(19):2324-30. PubMed ID: 10822383 [TBL] [Abstract][Full Text] [Related]
12. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Kanamori Y; Kigawa J; Itamochi H; Shimada M; Takahashi M; Kamazawa S; Sato S; Akeshima R; Terakawa N Clin Cancer Res; 2001 Apr; 7(4):892-5. PubMed ID: 11309338 [TBL] [Abstract][Full Text] [Related]
13. PTEN augments staurosporine-induced apoptosis in PTEN-null Ishikawa cells by downregulating PI3K/Akt signaling pathway. Wan X; Yokoyama Y; Shinohara A; Takahashi Y; Tamaya T Cell Death Differ; 2002 Apr; 9(4):414-20. PubMed ID: 11965494 [TBL] [Abstract][Full Text] [Related]
14. Positive feedback regulation between AKT activation and fatty acid synthase expression in ovarian carcinoma cells. Wang HQ; Altomare DA; Skele KL; Poulikakos PI; Kuhajda FP; Di Cristofano A; Testa JR Oncogene; 2005 May; 24(22):3574-82. PubMed ID: 15806173 [TBL] [Abstract][Full Text] [Related]
15. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Martelli AM; Tazzari PL; Tabellini G; Bortul R; Billi AM; Manzoli L; Ruggeri A; Conte R; Cocco L Leukemia; 2003 Sep; 17(9):1794-805. PubMed ID: 12970779 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells. Spinella F; RosanĂ² L; Di Castro V; Nicotra MR; Natali PG; Bagnato A Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139 [TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 inducing Mcl-1-dependent survival mechanism in human lung adenocarcinoma CL1.0 cells. Involvement of phosphatidylinositol 3-kinase/Akt pathway. Lin MT; Lee RC; Yang PC; Ho FM; Kuo ML J Biol Chem; 2001 Dec; 276(52):48997-9002. PubMed ID: 11585835 [TBL] [Abstract][Full Text] [Related]
18. Expression of PTEN in PTEN-deficient multiple myeloma cells abolishes tumor growth in vivo. Ge NL; Rudikoff S Oncogene; 2000 Aug; 19(36):4091-5. PubMed ID: 10962569 [TBL] [Abstract][Full Text] [Related]
19. Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line. Lee S; Choi EJ; Jin C; Kim DH Gynecol Oncol; 2005 Apr; 97(1):26-34. PubMed ID: 15790433 [TBL] [Abstract][Full Text] [Related]
20. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells. Di Popolo A; Memoli A; Apicella A; Tuccillo C; di Palma A; Ricchi P; Acquaviva AM; Zarrilli R Oncogene; 2000 Nov; 19(48):5517-24. PubMed ID: 11114729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]